Those who used the drug had a median progression-free survival of 7.4 months compared to 4.8 months for those who only received the chemotherapy with a placebo.
But this new drug comes with a hefty price tag, according to the Associated Press. The news outlet reported that atezolizumab costs about $13,400 per month.